Overview

This study aims to evaluate the diagnostic efficacy, safety, and clinical outcomes of thoracoscopic pleural biopsy in the management of pleural diseases.

Eligibility

Inclusion Criteria:

• Patients with suspected pleural disease who have been referred for thoracoscopic pleural biopsy
• Age: Adults aged 18 years and older
• Patients should have undergone necessary preoperative evaluations, including imaging studies (e.g., chest X-ray, CT scan) that indicate a need for biopsy.

Exclusion Criteria:

• Contraindications to Thoracoscopic Biopsy: Patients with contraindications to thoracoscopic biopsy
• Infeasibility of Procedure: Patients with anatomical or physiological factors that make thoracoscopic biopsy technically unfeasible or unsafe (e.g., severe pleural adhesions or distorted anatomy).
• Alternative Diagnoses: Patients who have been definitively diagnosed with a condition that does not require thoracoscopic biopsy for further evaluation.
• Pregnancy: Pregnant women may be excluded due to potential risks to the fetus and the need for specific procedural considerations.
• Inability to Provide Consent: Patients who are unable to provide informed consent due to cognitive impairment, language barriers, or other reasons.
• Participation in Concurrent Studies: Patients currently participating in other clinical studies that could interfere with the outcomes of this study or affect their eligibility.